The female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 in Rwanda currently stands at 18.7%, indicating a decrease of 0.1% (-0.5%) since 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Rwanda
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Rwanda
Female CVD, cancer, diabetes or CRD
More indicators for Rwanda
Out-of-pocket expenditure PPP per capita
intl dollar18
+intl dollar2
(2021)
Newborns protected against tetanus
97%
0%
(2022)
Female wasting in children
1.4%
-0.7%
(2020)
Birth registration
85.6%
+29.6%
(2020)
Female prevalence of HIV
0.9%
-0.1%
(2022)
Contraceptive modern method prevalence
58.4%
+10.9%
(2020)
Rwanda Female CVD, cancer, diabetes or CRD between 2000 and 2019
Period | Female CVD, cancer, diabetes or CRD | Change |
---|---|---|
2019 | 18.7% | -0.1% |
2018 | 18.8% | 0% |
2017 | 18.8% | -0.2% |
2016 | 19% | -0.2% |
2015 | 19.2% | -0.1% |
2014 | 19.3% | -0.1% |
2013 | 19.4% | -0.4% |
2012 | 19.8% | -0.3% |
2011 | 20.1% | -0.4% |
2010 | 20.5% | -0.5% |
2009 | 21% | -0.8% |
2008 | 21.8% | -0.6% |
2007 | 22.4% | -0.7% |
2006 | 23.1% | -0.8% |
2005 | 23.9% | -1.2% |
2004 | 25.1% | -1.7% |
2003 | 26.8% | -1.7% |
2002 | 28.5% | -1.7% |
2001 | 30.2% | -2.1% |
2000 | 32.3% |